Skip to main content
SpringerLink
Log in

Choices for treatment of hyperlipidaemia

  • Published:
Journal of Inherited Metabolic Disease

Abstract

Summary: A number of studies have established that lowering of serum cholesterol levels leads to striking reductions in cardiovascular events. Although children almost never experience myocardial infarction, stroke or coronary death, paediatric autopsy studies suggest that atherosclerosis starts in childhood. Moreover, the extent of atherosclerotic change in children can be correlated with the same risk factors, including serum cholesterol level, as identified in adults. As a result of these lines of evidence, the paediatric health care community has produced guidelines for treatment of children with hypercholesterolaemia, but has also debated the pros and cons of treatment. This controversy is unlikely to be resolved completely, because definitive studies would require several decades of follow-up and would raise serious ethical concerns. The purpose of this review is to summarize current views on the optimal approach to management of hyperlipidaemia in children, given current knowledge. We suggest that the child's sex, serum cholesterol level and family history of premature cardiovascular disease may be used to stratify risk. Children at exceptional high risk may be considered for pharmacological treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  • Arca M, Jokinen E (1998) Low density lipoprotein receptor mutations in a selected population of individuals with moderate hypercholesterolemia. Atherosclerosis 136: 187-194.

    Article  PubMed  CAS  Google Scholar 

  • Athyros VG, Papageorgiou AA, Kontopoulos AG (2002) Long-term treatment with atorvastatin in adolescent males with heterozygous familial hypercholesterolemia. Atherosclerosis 163: 205-256.

    Article  PubMed  CAS  Google Scholar 

  • Celermajer DS, Sorensen KE, Gooch VM, et al (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340: 1111-1115.

    Article  PubMed  CAS  Google Scholar 

  • Committee of Principal Investigators (1984) World Health Organization cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Lancet 2: 600-604.

    Google Scholar 

  • de Jongh S, Lilien MR, Bakker HD, Hutten BA, Kastelein JJP, Stroes ESG (2002) Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia. Atherosclerosis 163: 193-197.

    Article  PubMed  CAS  Google Scholar 

  • de Lorgeril M, Renaud S, Mamelle N, et al (1994) Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343: 1454-1459.

    Article  PubMed  CAS  Google Scholar 

  • Dennison BA, Jenkins PL, Pearson TA (1994) Challenges to implementing the current pediatric cholesterol screening guidelines into practice. Pediatrics 94: 296-302.

    PubMed  CAS  Google Scholar 

  • Dorr AE, Gundersen K, Schneider JC, Spencer TW, Martin WB (1978) Colestipol hydrochloride in hypercholesterolemic patients. Effect on serum cholesterol and mortality. J Chron Dis 31: 5-14.

    Article  PubMed  CAS  Google Scholar 

  • Downs JR, Clearfield M, Weis S, et al, for the AFCAPS/TexCAPS research group (1998) Primary prevention of acute coronary events with lovastatin in men and women with aver-age cholesterol levels. JAMA 279: 1615-1622.

    Article  PubMed  CAS  Google Scholar 

  • Ducobu J, Brasseur D, Chaudron JM, et al (1992) Simvastatin use in children (letter). Lancet 339: 1488.

    Article  PubMed  CAS  Google Scholar 

  • Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285: 2486-2497.

    Article  Google Scholar 

  • Frick MH, Elo O, Haapa K, et al (1987) Helsinski Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 317: 1237-1245.

    Article  PubMed  CAS  Google Scholar 

  • Gagné C, Gaudet D, Bruckert E, for the vEzetimibe Study Group) (2002) Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Circulation 105: 2469-2475.

    Article  PubMed  CAS  Google Scholar 

  • Gidding SS, Bookstein LC, Chomka EF (1998) Usefulness of electron beam tomography in adolescents and young adults with heterozygous familial hypercholesterolemia. Circulation 98: 2580-2583.

    PubMed  CAS  Google Scholar 

  • Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 7-22.

    Article  Google Scholar 

  • Kaistha A, Deckelbaum RJ, Starc TJ, Couch SC (2001) Overrestriction of dietary fat intake before formal nutritional counseling in children with hyperlipidemia. Arch Pediatr Adolesc Med 155: 1225-1230.

    PubMed  CAS  Google Scholar 

  • Klag MJ, Ford DE, Mead LA, et al (1993) Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 328: 313-318.

    Article  PubMed  CAS  Google Scholar 

  • Knipscheer HC, Boelen CCA, Kastelein JJP, et al (1996) Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia. Pediatr Res 39: 867-871.

    PubMed  CAS  Google Scholar 

  • Lambert M, Lupien P-J, Gange C, et al (1996) Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Pediatrics 97: 619-628.

    PubMed  CAS  Google Scholar 

  • Lavrencic A, Kosmina B, Keber I, et al (1996) Carotid intima-media thickness in young patients with familial hypercholesterolemia. Heart 76: 321-325.

    PubMed  CAS  Google Scholar 

  • Lipid Research Clinics Program (1984) The Lipid Research Clinics Coronary Primary Prevention Trial results: 1. Reduction in incidence of coronary heart disease. JAMA 251: 351-364.

    Article  Google Scholar 

  • Lu H, Higashikata T, Inazu A, et al (2002) Association of estrogen receptor-c gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 22: 821-827.

    CAS  Google Scholar 

  • National Cholesterol Education Program (1992) Report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 89: 525-584.

    Google Scholar 

  • Newman TB, Garber AM, Holtzman NA, Hulley SB (1995) Problems with the report of the expert panel on blood cholesterol levels in children and adolescents. Arch Pediatr Adolesc Med 149: 241-247.

    PubMed  CAS  Google Scholar 

  • Nicholls P, Young IS, Graham CA (1998) Genotype/phenotype correlations in familial hypercholesterolaemia. Curr Opin Lipidol 9: 313-317.

    Article  PubMed  CAS  Google Scholar 

  • Obarzanek E, Kimm SY, Barton BA, et al (2001) Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC). Pediatrics 107: 256-264.

    Article  PubMed  CAS  Google Scholar 

  • O'Driscoll G, Green D, Taylor RR (1997) Simvastatin, an HMB-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95: 1126-1137.

    PubMed  Google Scholar 

  • Ose L, Tonstad S (1995) The detection and management of dyslipidaemia in children and adolescents. Acta Paediatr 84: 1213-1215.

    PubMed  CAS  Google Scholar 

  • Pedersen TR, Wilhelmsen L, Faergeman O, et al (2000) Follow-up study of patients randomized in the Scandinavian Simvastatin Survival Study (4S) of cholesterol lowering. Am J Cardiol 86: 257-262.

    Article  PubMed  CAS  Google Scholar 

  • Rubba P, Iannuzzi A, Faccenda F, De Leo F, Pauciullo P (2001) Non-invasive vascular detection of early signs of atherosclerosis in hypercholesterolemic children: why and how. Nutr Metab Cardiovasc Dis 5(supplement): 10-15.

    Google Scholar 

  • Scientific Steering Committee on behalf of the Simon Broome Register Group (1999) Mortality in treated heterozygous familial hyercholesterolaemia: implications for clinical management. Atherosclerosis 142: 105-112.

    Article  Google Scholar 

  • Shepherd J, Cobbe SM, Ford I, for the West of Scotland Coronary Prevention Study Group (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333: 1301-1307.

    Article  PubMed  CAS  Google Scholar 

  • Simell O, Niinikoski H, R6nnemaa T, et al (2000) Special Turku Coronary Risk Factor Intervention Project of babies (STRIP). Am J Clin Nutr 72 (supplement): 1316S-1331S.

    PubMed  CAS  Google Scholar 

  • Sinzinger H, Schmid P, Pirich CH, et al (1992) Treatment of hypercholesterolaemia in children. Lancet 340: 548-549.

    Article  PubMed  CAS  Google Scholar 

  • Sinzinger H, Mayr F, Schmid P, et al (1994) Sleep disturbance and appetite loss after lovastatin. Lancet 343: 973.

    Article  PubMed  CAS  Google Scholar 

  • Sorensen KE, Celermajer DS, Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield JE (1994) Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolaemia and is related to the lipoprotein(a) level. J Clin Invest 93: 50-55.

    Article  PubMed  CAS  Google Scholar 

  • Stefanutti C, Lucani G, Vivenzio A, Di Giacomo S (1999) Drugs Exp Clin Res 15: 23-28.

    Google Scholar 

  • Stein EA, Illingworth DR, Kwiterovich PO Jr, et al (1999) Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia. A randomized con-trolled trial. JAMA 281: 137-144.

    Article  PubMed  CAS  Google Scholar 

  • Strong JP, Zieske AW, Malcom GT (2001) Lipoproteins and atherosclerosis in children: an early marriage? Nutr Metab Cardiovasc Dis 5(supplement): 16-22.

    Google Scholar 

  • Tonstad S (1996) Familial hypercholesterolaemia: a pilot study of parents' and children's concerns. Acta Paediatr 85: 1307-1313.

    PubMed  CAS  Google Scholar 

  • Tonstad S, Sivertsen M (1997) Dietary adherence in children with familial hyper-cholesterolemia. Am J Clin Nutr 65: 1018-1026.

    PubMed  CAS  Google Scholar 

  • Tonstad S, Leren TP, Sivertsen M, Ose L (1995) Determinants of lipid levels among children with heterozygous familial hypercholesterolemia in Norway. Arterioscler Thromb Vasc Biol 15: 1009-1014.

    PubMed  CAS  Google Scholar 

  • Tonstad S, Joakimsen O, Stensland-Bugge E, et al (1996a) Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and controls. Arterioscler Thromb Vasc Biol 16: 984-991.

    PubMed  CAS  Google Scholar 

  • Tonstad S, Knudtzon J, Sivertsen M, Refsum H, Ose L (1996b) Efficacy and safety of cholestyramine in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr 129: 42-49.

    Article  PubMed  CAS  Google Scholar 

  • Umans-Eckenhausen MAW, Defesche JC, Siljbrands EJ, Scheerder RL, Kastelein JJ (2001) Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet 357: 165-168.

    Article  PubMed  CAS  Google Scholar 

  • Valente AM, Newburger JW, Lauer RM (2001) Hyperlipidemia in children and adolescents. Am Heart J 142: 433-439.

    Article  PubMed  CAS  Google Scholar 

  • Williams CL, Hayman LL, Daniels SR et al (2002) Cardiovascular health in childhood. A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 106: 143-160.

    Article  PubMed  Google Scholar 

  • Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Py6rdld K (1998) Recommendations of the second joint task force of European and other societies on coronary prevention. Prevention of coronary heart disease in clinical practice. Eur Heart J 19: 1434-1503.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Preventive Cardiology, Preventive Medicine Clinic, Ullevål University Hospital, N-0407, Oslo, Norway

    S. Tonstad

Authors
  1. S. Tonstad
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tonstad, S. Choices for treatment of hyperlipidaemia. J Inherit Metab Dis 26, 289–298 (2003). https://doi.org/10.1023/A:1024401720730

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024401720730

Keywords

Search

Navigation